“…Among inorganic nanodrug candidates, polyoxometalates (POMs) are multi- metallic and polyanionic oxides which have shown interesting potential applications as antibacterial, antiviral, antitumoral agents (Rhule et al, 1998 ; Hasenknopf, 2005 ; Bijelic et al, 2018 ). Such biological activity mainly derives from their redox behavior, their biomimetic activity, or from their capability to interact with biological macromolecules through electrostatic interactions (Prudent et al, 2008 ; Li et al, 2016 ). Due to their nanosized dimension and polyanionic charge, indeed, POMs can easily interact with positively charged domains of peptides and proteins, affecting their secondary/tertiary structure and altering their functionalities (Wu et al, 2005 ; Zhang et al, 2008 ; Geng et al, 2011 ).…”